Literature DB >> 15521962

Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease.

Frank Fischer1, Helmut Schulte, Subburaman Mohan, Mira-Christine Tataru, Ekkehart Köhler, Gerd Assmann, Arnold von Eckardstein.   

Abstract

OBJECTIVE: IGFs and their binding proteins (IGFBPs) are produced both systemically and locally by cells of the cardiovascular system. As growth promoters, they may play a role in atherosclerosis.
DESIGN: Case-control, cross-sectional. PATIENTS: A total of 95 nondiabetic male patients with coronary heart disease (CHD) and 92 probands from the Prospective Cardiovascular Munster (PROCAM) who were below the age of 60 years and matched by age, body mass index (BMI) and smoking habits. MEASUREMENTS: We analysed the strength and independence of associations of angiographically assessed presence of CHD with BMI, systolic and diastolic blood pressure, total, high-density lipoprotein (HDL) and LDL cholesterol, triglycerides, lipoprotein(a), apolipoproteins A-I and B, total and free IGF-I, IGF-II, IGFBP-1, IGFBP-3, IGFBP-5, acid-labile subunit (ALS), insulin, C-peptide, testosterone, DHEAS and sex hormone binding globulin.
RESULTS: Using multivariate statistical analysis, the presence of CHD had significant positive associations with total IGF-I, IGFBP-5, ALS and IGFBP-3. These associations were independent of each other as well as of traditional risk factors, insulin and sex hormones.
CONCLUSION: These observations may indicate a pathogenetic role of the GH/IGF axis in coronary atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15521962     DOI: 10.1111/j.1365-2265.2004.02136.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  18 in total

Review 1.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

2.  Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.

Authors:  Yusuke Higashi; Sergiy Sukhanov; Shaw-Yung Shai; Svitlana Danchuk; Richard Tang; Patricia Snarski; Zhaohui Li; Patricia Lobelle-Rich; Meifang Wang; Derek Wang; Hong Yu; Ronald Korthuis; Patrice Delafontaine
Journal:  Circulation       Date:  2016-05-06       Impact factor: 29.690

3.  Serum IGF-I and hormonal responses to incremental exercise in athletes with and without left ventricular hypertrophy.

Authors:  Aleksandra Zebrowska; Zbigniew Gąsior; Józef Langfort
Journal:  J Sports Sci Med       Date:  2009-03-01       Impact factor: 2.988

Review 4.  PAPP-A and the IGF system in atherosclerosis: what's up, what's down?

Authors:  Lasse B Steffensen; Cheryl A Conover; Claus Oxvig
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-09-13       Impact factor: 4.733

Review 5.  Aging, atherosclerosis, and IGF-1.

Authors:  Yusuke Higashi; Sergiy Sukhanov; Asif Anwar; Shaw-Yung Shai; Patrice Delafontaine
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-05       Impact factor: 6.053

6.  Hepatic JAK2 protects against atherosclerosis through circulating IGF-1.

Authors:  Tharini Sivasubramaniyam; Stephanie A Schroer; Angela Li; Cynthia T Luk; Sally Yu Shi; Rickvinder Besla; David W Dodington; Adam H Metherel; Alex P Kitson; Jara J Brunt; Joshua Lopes; Kay-Uwe Wagner; Richard P Bazinet; Michelle P Bendeck; Clinton S Robbins; Minna Woo
Journal:  JCI Insight       Date:  2017-07-20

7.  Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age.

Authors:  A Colao; S Spiezia; C Di Somma; R Pivonello; P Marzullo; F Rota; T Musella; R S Auriemma; M C De Martino; G Lombardi
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

Review 8.  IGF-1, oxidative stress and atheroprotection.

Authors:  Yusuke Higashi; Sergiy Sukhanov; Asif Anwar; Shaw-Yung Shai; Patrice Delafontaine
Journal:  Trends Endocrinol Metab       Date:  2010-01-12       Impact factor: 12.015

9.  Plasma levels of mannan-binding lectin (MBL)-associated serine proteases (MASPs) and MBL-associated protein in cardio- and cerebrovascular diseases.

Authors:  V Frauenknecht; S Thiel; L Storm; N Meier; M Arnold; J-P Schmid; H Saner; V Schroeder
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

Review 10.  Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging.

Authors:  Yusuke Higashi; Henry C Quevedo; Summit Tiwari; Sergiy Sukhanov; Shaw-Yung Shai; Asif Anwar; Patrice Delafontaine
Journal:  Front Horm Res       Date:  2014-06-10       Impact factor: 2.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.